These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 32508645)

  • 1. Monoterpenes Differently Regulate Acid-Sensitive and Mechano-Gated K
    Arazi E; Blecher G; Zilberberg N
    Front Pharmacol; 2020; 11():704. PubMed ID: 32508645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein and Chemical Determinants of BL-1249 Action and Selectivity for K
    Pope L; Arrigoni C; Lou H; Bryant C; Gallardo-Godoy A; Renslo AR; Minor DL
    ACS Chem Neurosci; 2018 Dec; 9(12):3153-3165. PubMed ID: 30089357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A regulatory domain in the K
    Arazi E; Blecher G; Zilberberg N
    Mol Cell Neurosci; 2020 Jun; 105():103496. PubMed ID: 32320829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of K
    Lee H; Lolicato M; Arrigoni C; Minor DL
    Methods Enzymol; 2021; 653():151-188. PubMed ID: 34099170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temperature sensitivity of two-pore (K2P) potassium channels.
    Schneider ER; Anderson EO; Gracheva EO; Bagriantsev SN
    Curr Top Membr; 2014; 74():113-33. PubMed ID: 25366235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered expression of two-pore domain potassium (K2P) channels in cancer.
    Williams S; Bateman A; O'Kelly I
    PLoS One; 2013; 8(10):e74589. PubMed ID: 24116006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vernakalant activates human cardiac K(2P)17.1 background K(+) channels.
    Seyler C; Schweizer PA; Zitron E; Katus HA; Thomas D
    Biochem Biophys Res Commun; 2014 Aug; 451(3):415-20. PubMed ID: 25108155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of the human detrusor to stretch is regulated by TREK-1, a two-pore-domain (K2P) mechano-gated potassium channel.
    Lei Q; Pan XQ; Chang S; Malkowicz SB; Guzzo TJ; Malykhina AP
    J Physiol; 2014 Jul; 592(14):3013-30. PubMed ID: 24801307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. K
    Lolicato M; Arrigoni C; Mori T; Sekioka Y; Bryant C; Clark KA; Minor DL
    Nature; 2017 Jul; 547(7663):364-368. PubMed ID: 28693035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of temperature-sensitive leak K
    Viatchenko-Karpinski V; Ling J; Gu JG
    Mol Brain; 2018 Jul; 11(1):40. PubMed ID: 29980241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stretch-activated two-pore-domain (K
    Schmidt C; Wiedmann F; Kallenberger SM; Ratte A; Schulte JS; Scholz B; Müller FU; Voigt N; Zafeiriou MP; Ehrlich JR; Tochtermann U; Veres G; Ruhparwar A; Karck M; Katus HA; Thomas D
    Prog Biophys Mol Biol; 2017 Nov; 130(Pt B):233-243. PubMed ID: 28526353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of two-pore-domain (K2P) potassium leak channels by the tyrosine kinase inhibitor genistein.
    Gierten J; Ficker E; Bloehs R; Schlömer K; Kathöfer S; Scholz E; Zitron E; Kiesecker C; Bauer A; Becker R; Katus HA; Karle CA; Thomas D
    Br J Pharmacol; 2008 Aug; 154(8):1680-90. PubMed ID: 18516069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Polysite Pharmacology of TREK K
    Pope L; Minor DL
    Adv Exp Med Biol; 2021; 1349():51-65. PubMed ID: 35138610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of two-pore domain potassium channels in rat cerebellar granule neurons.
    Burgos P; Zúñiga R; Domínguez P; Delgado-López F; Plant LD; Zúñiga L
    Biochem Biophys Res Commun; 2014 Oct; 453(4):754-60. PubMed ID: 25305496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation and heart failure-associated remodeling of two-pore-domain potassium (K
    Wiedmann F; Schulte JS; Gomes B; Zafeiriou MP; Ratte A; Rathjens F; Fehrmann E; Scholz B; Voigt N; Müller FU; Thomas D; Katus HA; Schmidt C
    Basic Res Cardiol; 2018 Jun; 113(4):27. PubMed ID: 29881975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of two-pore K
    Chai S; Wan X; Nassal DM; Liu H; Moravec CS; Ramirez-Navarro A; Deschênes I
    Am J Physiol Heart Circ Physiol; 2017 Jun; 312(6):H1144-H1153. PubMed ID: 28341634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Targets for Old Drugs: Cardiac Glycosides Inhibit Atrial-Specific K
    Schmidt C; Wiedmann F; Gaubatz AR; Ratte A; Katus HA; Thomas D
    J Pharmacol Exp Ther; 2018 Jun; 365(3):614-623. PubMed ID: 29643254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cardiac two-pore-domain K+ (K2P) channels by the antiarrhythmic drug vernakalant--comparison with flecainide.
    Seyler C; Li J; Schweizer PA; Katus HA; Thomas D
    Eur J Pharmacol; 2014 Feb; 724():51-7. PubMed ID: 24374008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated expression of TREK-TRAAK K
    Zhang XT; Xu Z; Shi KP; Guo DL; Li H; Wang L; Zhu XB
    Int J Ophthalmol; 2019; 12(6):924-929. PubMed ID: 31236347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-Pore-Domain Potassium (K
    Wiedmann F; Frey N; Schmidt C
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.